COR vs COSM
Cencora, Inc. and Cosmos Health Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | COR | COSM |
|---|---|---|
| Revenue | $321.3B | $65.3M |
| Net income | $1.6B | $-19.1M |
| Gross margin | 3.6% | 12.1% |
| Net margin | 0.5% | −29.3% |
| Return on equity | 144.3% | −89.1% |
| Diluted EPS | $7.96 | −$0.63 |
| Dividend / share | $2.20 | — |
| Payout ratio | 28.1% | — |
| Free cash flow | $3.2B | $-8.5M |
| Equity | $1.5B | $18.4M |
| Net debt / equity | 2.19× | 0.17× |
| Current ratio | 0.90× | 1.00× |
| Revenue CAGR 5y | 11.1% | 3.3% |
| Profit CAGR 5y | — | — |
COR bills 4923.0× the revenue of COSM, and COSM closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | COR | COSM |
|---|---|---|
| FY2025 | $321.3B | $65.3M |
| FY2024 | $294.0B | $54.4M |
| FY2023 | $262.2B | $53.4M |
| FY2022 | $238.6B | $50.3M |
| FY2021 | $214.0B | $56.2M |
| FY2020 | $189.9B | $55.4M |
| FY2019 | $179.6B | $39.7M |
| FY2018 | $167.9B | $37.1M |
| FY2017 | $153.1B | $30.0M |
| FY2016 | $146.8B | $6.8M |
Net income by year
Bottom line
| Fiscal year | COR | COSM |
|---|---|---|
| FY2025 | $1.6B | $-19.1M |
| FY2024 | $1.5B | $-16.2M |
| FY2023 | $1.7B | $-18.5M |
| FY2022 | $1.7B | $-13.8M |
| FY2021 | $1.5B | $-8.0M |
| FY2020 | $-3.4B | $820,786 |
| FY2019 | $855.4M | $-3.3M |
| FY2018 | $1.7B | $-9.1M |
| FY2017 | $364.5M | $-6.2M |
| FY2016 | $1.4B | $-601,002 |
Advertisement
AdSense · Rectangle 336×280